ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,047, issued on March 17, was assigned to Neuromagen Pharma Ltd (Beersheva, Israel).
"Telomerase activating compounds for use in fertility and related applications" was invented by Esther Priel (Beersheva, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to methods and uses of a series of compounds and compositions comprising the same for treating diseases, disorders and/or conditions related to fertility and preserving same and conditions related to same. In some aspects, the compounds and or compositions as herein described promote, improve, recover or restore fertility in a subject in need thereof, including...